[1]
Burney, I.A., Kakaria, A.K. and Al-Jahdhami, S. 2021. Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis. Sultan Qaboos University Medical Journal. 21, 2 (Jun. 2021), e327–328. DOI:https://doi.org/10.18295/squmj.2021.21.02.027.